The mechanisms of QRQZ on NASH were associated with modulating gut microbiota, thereby inducing the tight junction of gut barrier, reducing the endotoxemia and inhibiting the activation of TLR4/NF-κB signaling pathway in liver (Figure 6). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.